跳至主要内容
临床试验/ACTRN12623001172695
ACTRN12623001172695尚未招募Unknown

Breast Lymphoedema and Radiation Treatment Randomised Controlled Trial –Ultra versus Moderate Breast Hypofractionation Radiation Treatment (HYPO-BL)

Gosford Hospital0 个研究点目标入组 200 人开始时间: 2023年11月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
Female

入选标准

  • 1.Women aged 50 years or older
  • 2. Unilateral DCIS or early-stage invasive breast cancer (Stage Tis-T3, N0, M0)
  • 3. Breast conservation surgery
  • 4. Complete microscopic resection i.e. negative margins
  • 5. Neoadjuvant systemic therapy to downstage cT3-T4 breast cancer is accepted if there is not an indication to irradiate the lymph nodes or treat with bolus
  • 6. Ability to understand and willingness to sign written informed consent
  • 7. Available for 2 years of face-to face follow-up

排除标准

  • 1. Prior history of breast cancer or DCIS
  • 2. Bilateral breast cancer or bilateral breast surgery (e.g. symmetrising surgery)
  • 3. History of breast implants or breast reconstructive surgery in either breast
  • 4. Use of bolus during radiotherapy
  • 5. Prone breast radiation treatment
  • 6. Conditions where the patient cannot complete radiation treatment or attend follow-up, or a condition where the treating oncologist thinks the patient should not participate in the trial e.g. language problems.
  • 7. Unwilling or unable to give informed consent

研究者

相似试验